Skip to content
Vaccine & Immunotherapy Center
 
  • ABOUT
    • MISSION
    • Advisors
    • Management Team
    • Principal Investigators
    • collaborators
  • TECH
    • Infectious Disease
    • Immuno-oncology
    • Regenerative Medicine & Immunotherapy
    • High Dimensional Immunology
  • LABS
    • Dai Lab
    • Dogan Lab
    • Gelfand Lab
    • Gemechu Lab
    • Mukerji Lab
    • Poznansky Lab
    • Reeves Lab
    • Sîrbulescu Lab
  • NEWS
  • DONATE
  • VIC-HUG
    • Recent Press
  • CAREERS
  • ABOUT
    • MISSION
    • Advisors
    • Management Team
    • Principal Investigators
    • collaborators
  • TECH
    • Infectious Disease
    • Immuno-oncology
    • Regenerative Medicine & Immunotherapy
    • High Dimensional Immunology
  • LABS
    • Dai Lab
    • Dogan Lab
    • Gelfand Lab
    • Gemechu Lab
    • Mukerji Lab
    • Poznansky Lab
    • Reeves Lab
    • Sîrbulescu Lab
  • NEWS
  • DONATE
  • VIC-HUG
    • Recent Press
  • CAREERS
Vaccine & Immunotherapy Center
 
  • ABOUT
    • MISSION
    • Advisors
    • Management Team
    • Principal Investigators
    • collaborators
  • TECH
    • Infectious Disease
    • Immuno-oncology
    • Regenerative Medicine & Immunotherapy
    • High Dimensional Immunology
  • LABS
    • Dai Lab
    • Dogan Lab
    • Gelfand Lab
    • Gemechu Lab
    • Mukerji Lab
    • Poznansky Lab
    • Reeves Lab
    • Sîrbulescu Lab
  • NEWS
  • DONATE
  • VIC-HUG
    • Recent Press
  • CAREERS
  • ABOUT
    • MISSION
    • Advisors
    • Management Team
    • Principal Investigators
    • collaborators
  • TECH
    • Infectious Disease
    • Immuno-oncology
    • Regenerative Medicine & Immunotherapy
    • High Dimensional Immunology
  • LABS
    • Dai Lab
    • Dogan Lab
    • Gelfand Lab
    • Gemechu Lab
    • Mukerji Lab
    • Poznansky Lab
    • Reeves Lab
    • Sîrbulescu Lab
  • NEWS
  • DONATE
  • VIC-HUG
    • Recent Press
  • CAREERS

Dr. Mark Poznansky speaks on B cell therapy in the context of regenerative medicine at the 2024 First Look at the World Medical Innovation Forum.

  • Posted on October 17, 2024
Dr. Poznansky discusses research at VIC investigating B cells as a potential cell therapy for treating neural injury. Research in the VIC lab demonstrates B cells to be both neuroprotective and neuroregenerative in the context of intracranial hemorrhage in a murine mouse model.
FacebookTwitter

Recommended Posts

Alexis Jolly, VIC summer student, presents innovative technology at the international SPIE Photonics West Conference following summer at VIC, Wellman Centre, and MGH
Saumya Maheshwari and James Aspden of the Sîrbulescu lab share the 2024 Arthur Fonville Award for their research in stroke!
Allogeneic B cell immunomodulatory therapy in amyotrophic lateral sclerosis
Immune Dysregulation and Vaccine Response in Rare Blood Cancers: Insights from a Pilot Study
Vaccine & Immunotherapy Center
Accelerating discovery and development of new products addressing unmet clinical need.
Facebook-f Twitter Youtube

INFORMATION

  • CAREERS
  • Directions
  • Advisors
  • Management
  • Collaborators
  • Support VIC

CONTACT

149 13th Street, 5th Floor
Charlestown Navy Yard,
MA 02129-2020

Phone  :  1-617-643-2098
Email    :  VIC@partners.org

© 2023 VACCINE & IMMUNOTHERAPY CENTER. ALL RIGHTS RESERVED |  Site by OLP